Cardinal Health (NYSE:CAH) Price Target Raised to $208.00

Cardinal Health (NYSE:CAH) had its price objective increased by equities researchers at Deutsche Bank Aktiengesellschaft from $195.00 to $208.00 in a research note issued to investors on Tuesday,MarketScreener reports. The firm currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 0.68% from the company’s previous close.

Several other research analysts have also recently weighed in on the stock. Evercore ISI boosted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Mizuho boosted their target price on Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. Citigroup raised their price target on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Leerink Partners upped their target price on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research report on Monday. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $206.57.

Cardinal Health Stock Up 0.2%

Cardinal Health stock opened at $206.60 on Tuesday. The stock has a 50-day simple moving average of $167.82 and a 200 day simple moving average of $160.05. The stock has a market capitalization of $49.09 billion, a price-to-earnings ratio of 32.05, a P/E/G ratio of 1.39 and a beta of 0.72. Cardinal Health has a 12-month low of $114.60 and a 12-month high of $208.32.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. The company’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts anticipate that Cardinal Health will post 7.95 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CAH. J.W. Cole Advisors Inc. acquired a new position in shares of Cardinal Health in the 1st quarter valued at approximately $1,095,000. Teachers Retirement System of The State of Kentucky lifted its stake in Cardinal Health by 3.3% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 18,672 shares of the company’s stock valued at $2,573,000 after buying an additional 588 shares in the last quarter. GW&K Investment Management LLC boosted its holdings in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after buying an additional 144 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH increased its position in shares of Cardinal Health by 5.2% during the first quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 206,157 shares of the company’s stock worth $28,402,000 after acquiring an additional 10,207 shares in the last quarter. Finally, Efficient Advisors LLC bought a new stake in Cardinal Health in the 1st quarter valued at $892,000. 87.17% of the stock is owned by institutional investors and hedge funds.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.